Aegerion Pharmaceuticals, Inc.
Overview
Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for patients with debilitating rare diseases. Aegerion operates as a subsidiary of Novelion Therapeutics, a company that develops treatments for rare diseases characterized by high unmet needs.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Aegerion Pharmaceuticals, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.